Protocol of the randomized control trial: the WiseApp trial for improving health outcomes in PLWH (WiseApp)

Abstract

Background Poor adherence to antiretroviral therapy (ART) is one of the primary barriers to viral load suppression. mHealth technology can help overcome challenges with ART adherence. This paper outlines the protocol for the WiseApp randomized control trial. The WiseApp contains real-time medication monitoring linking an electronic pill bottle and fitness tracker to the app, helping persons living with HIV (PLWH) self-manage their medication adherence and improve their overall quality of life. The primary objective of the trial is to test the effect of the WiseApp's medication adherence features on antiretroviral adherence in underserved PLWH in New York City. Methods This ongoing study is a two-arm randomized control trial. Participants are randomized 1:1 to the WiseApp intervention arm or the control arm at baseline and followed for 6 months. Eligibility criteria include: 18 years of age, have a diagnosis of HIV, speak and understand English or Spanish, live in the United States, own a smartphone, currently taking ART medications, and report the past 30 days adherence of 80% or less as measured using the Visual Analogue Scale (VAS), or have a viral load of over 400 copies/mL. The sample size for the trial is 200 people. All study participants receive the WiseApp, a CleverCap electronic pill bottle, and a fitness tracker. The intervention group also receives videos and health surveys centered on medication adherence and managing living with HIV as well as medication reminders. In contrast, the control group receives walk step reminders, videos, and surveys focused on overall wellness. Discussion The WiseApp Trial has the potential to improve HIV self-management applications, being one of the few randomized controlled trials of a mHealth medication adherence and HIV self-management application in the United States. The trial could also bring new opportunities for advancement in reaching economically disenfranchised and underserved populations in the United States. The real-time monitoring of the WiseApp has the potential to help providers initiate interventions to help patients resume treatment before drug resistance begins. Trial registration This trial was registered with ClinicalTrials.gov (NCT03205982) on July 2, 2017.

Efficacy of a password‐protected, pill‐dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery

“…The system piloted in this study was designed with the prevention of opioid misuse and dependence in mind. Comparable existing systems are designed primarily to promote adherence and to support the treatment of opioid use disorder, 57,58 emphasizing features such as once‐daily dosing and weekly in‐person refills. The system evaluated here, by contrast, is intended to help patients use shorter prescriptions of opioids more safely and effectively.…”

Intervention to Improve Antiretroviral Adherence and Quality of Life on Hiv/Aids : A Systematic Review

“…In addition, M-intervention improves ARV drug compliance in the time and dosage aspects of drug administration for sustainability drug adherence (Hardy et al, 2011). In addition to adherence to treatment, mobile interventions containing real-time monitoring of medication linking an electronic pill bottle and fitness tracker to the app, helping people living with HIV (ODHA) manage their own treatment compliance and improving their overall quality of life (Flynn et al, 2020) Mobile phone facilities such as SMS and WeChat were developed by giving a message as a reminder to take medication, given 30 minutes before the patient's schedule to take medication. In addition to reminders, education is either online or directly provided to improve the patient's knowledge of drug use and have an impact on the patient's compliance with taking the drug.…”

“…Human Immunodeficiency Virus (HIV) infection is one of the serious public health problems that can cause widespread problems that include physical,social, and emotional problems (Flynn et al, 2020). HIV is the cause of an epidemic in public health that has impacted millions of people around the world.…”

“…Kemenkes RI, 2014). Four factors have been reported as predictors of adherence to antiretroviral treatment problems: regimen characteristics, patient factors, doctor-patient relationships and system care Each of these factors plays an important role; However, research shows that one of the most common forms of noncompliance is forgetting to take medication (Flynn et al, 2020). Non-compliance with ARV poses several potentially serious health problems, including a higher viral load of HIV, faster progression into AIDS, and an increased risk of resistance to HIV treatment (Moore et al, 2015).…”

Avaliação de usabilidade de aplicativo móvel para pacientes com cateter central de inserção periférica

“…Uma vez que a utilização destas tecnologias promove a educação dialógica e participativa em saúde preconizada por Paulo Freire, inicia-se um processo de conscientização dos pacientes para além do ambiente hospitalar, por meio da co-construção de conhecimento a partir de seus próprios contextos e demandas em domicílio (7) . Assim, tem crescido o número de estudos que abordam diferentes tipos de interações com pacientes com o objetivo de orientar, monitorar e incentivar a adesão ao tratamento de doenças crônicas, contagiosas e psiquiátricas (8)(9)(10) .…”